Access this stock data via API
Subscribe
PentixaPharm Holding AG
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 118K 24K 31K 59K
Cost of revenue 3.7M -4.7M -3.9M -2.5M
Gross profit -3.6M 4.7M 4.0M 2.6M
Operating expense
Research & development 8.3M 4.3M 2.9M
Selling general and admin 472K 1.8M 428K 117K
Other operating expenses 1.2M 96K 11K 4K
Operating income -17.6M -6.2M -2.2M -1.6M
Non operating interest income
Income 475K 130K 0 0
Expense 53K 183K 0 1K
Other income expense
Pretax income -16.6M -6.2M -779K -1.7M
Tax provision -3.7M 1.4M 1.2M 762K
Net income -12.8M -7.6M -2.0M -2.5M
Basic EPS -0.5 -0.3 -0.1
Diluted EPS -0.5 -0.3 -0.1
Basic average shares 24.8M 24.8M 24.8M
Diluted average shares 24.8M 24.8M 24.8M
EBITDA 1.9M -5.9M -665K -1.6M
Net income from continuing op. -12.8M
Minority interests
Preferred stock dividends 0 0 0 0
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 22 minutes

09:12
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).